Amir Ghorbani Haghjo

649 total citations
17 papers, 532 citations indexed

About

Amir Ghorbani Haghjo is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry. According to data from OpenAlex, Amir Ghorbani Haghjo has authored 17 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Clinical Biochemistry. Recurrent topics in Amir Ghorbani Haghjo's work include Chronic Kidney Disease and Diabetes (6 papers), Advanced Glycation End Products research (6 papers) and Diabetes Treatment and Management (3 papers). Amir Ghorbani Haghjo is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Advanced Glycation End Products research (6 papers) and Diabetes Treatment and Management (3 papers). Amir Ghorbani Haghjo collaborates with scholars based in Iran and Denmark. Amir Ghorbani Haghjo's co-authors include Davoud Sanajou, Hassan Argani, Somayeh Aslani, Saeed Nazari Soltan Ahmad, Mehran Mesgari Abbasi, Jalil Rashedi, Leila Roshangar, Nadereh Rashtchizadeh, Siavoush Dastmalchi and Ali Dastranj Tabrizi and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Experimental Eye Research.

In The Last Decade

Amir Ghorbani Haghjo

16 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Ghorbani Haghjo Iran 12 157 152 151 99 66 17 532
Davoud Sanajou Iran 16 242 1.5× 161 1.1× 167 1.1× 121 1.2× 87 1.3× 26 740
Sachin V. Suryavanshi India 10 129 0.8× 85 0.6× 139 0.9× 53 0.5× 43 0.7× 13 504
Sonia Sifuentes-Franco Mexico 8 153 1.0× 78 0.5× 94 0.6× 50 0.5× 51 0.8× 19 512
Hong Du China 14 354 2.3× 136 0.9× 109 0.7× 77 0.8× 113 1.7× 35 714
Jinying Wei China 13 331 2.1× 95 0.6× 81 0.5× 128 1.3× 76 1.2× 22 647
Hanaa N. Al‐Ajmi Saudi Arabia 8 141 0.9× 59 0.4× 102 0.7× 37 0.4× 36 0.5× 8 386
Yongli Zhan China 13 185 1.2× 55 0.4× 85 0.6× 203 2.1× 40 0.6× 33 636
Ruhan Jia China 11 146 0.9× 41 0.3× 84 0.6× 115 1.2× 37 0.6× 31 426
Hengjiang Guo China 13 247 1.6× 73 0.5× 56 0.4× 196 2.0× 76 1.2× 14 647

Countries citing papers authored by Amir Ghorbani Haghjo

Since Specialization
Citations

This map shows the geographic impact of Amir Ghorbani Haghjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Ghorbani Haghjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Ghorbani Haghjo more than expected).

Fields of papers citing papers by Amir Ghorbani Haghjo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Ghorbani Haghjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Ghorbani Haghjo. The network helps show where Amir Ghorbani Haghjo may publish in the future.

Co-authorship network of co-authors of Amir Ghorbani Haghjo

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Ghorbani Haghjo. A scholar is included among the top collaborators of Amir Ghorbani Haghjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Ghorbani Haghjo. Amir Ghorbani Haghjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sorkhabi, Rana, et al.. (2022). Assessment of tear inflammatory cytokines concentration in patients with diabetes with varying severity of involvement. Experimental Eye Research. 224. 109233–109233. 13 indexed citations
2.
Meshkini, Ali, et al.. (2021). S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein in Patients with Mild Traumatic Brain Injury.. SHILAP Revista de lepidopterología. 9(4). 183–187. 4 indexed citations
3.
Kalantary‐Charvadeh, Ashkan, et al.. (2020). Inhibition of USP14 induces ER stress–mediated autophagy without apoptosis in lung cancer cell line A549. Cell Stress and Chaperones. 25(6). 909–917. 21 indexed citations
4.
Haghjo, Amir Ghorbani, et al.. (2020). Sodium‐glucose co‐transporters and diabetic nephropathy: Is there a link with toll‐like receptors?. Clinical and Experimental Pharmacology and Physiology. 47(6). 919–926. 11 indexed citations
5.
Rashtchizadeh, Nadereh, Amir Ghorbani Haghjo, Hassan Argani, et al.. (2020). Protection of renal damage by HMG-CoA inhibitors: A comparative study between atorvastatin and rosuvastatin.. SHILAP Revista de lepidopterología. 23(2). 206–213. 7 indexed citations
6.
Rashedi, Jalil, Amir Ghorbani Haghjo, Mehran Mesgari Abbasi, et al.. (2019). Anti-tumor Effect of Quercetin Loaded Chitosan Nanoparticles on Induced Colon Cancer in Wistar Rats. Advanced Pharmaceutical Bulletin. 9(3). 409–415. 45 indexed citations
7.
Haghjo, Amir Ghorbani, Hassan Argani, Leila Roshangar, et al.. (2019). Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis.. SHILAP Revista de lepidopterología. 22(4). 384–390. 79 indexed citations
8.
Sanajou, Davoud, Amir Ghorbani Haghjo, Hassan Argani, et al.. (2018). Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the rat. European Journal of Pharmacology. 842. 40–48. 24 indexed citations
9.
Hajialilo, Mehrzad, et al.. (2018). Association of systemic lupus erythematosus activity with serum levelsof sTWEAK and CD160: A cross-sectional study. SHILAP Revista de lepidopterología. 6(3). 121–128. 1 indexed citations
10.
Sanajou, Davoud, Amir Ghorbani Haghjo, Hassan Argani, et al.. (2018). FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats. Journal of Physiology and Biochemistry. 74(3). 467–478. 25 indexed citations
11.
Haghjo, Amir Ghorbani, Hassan Argani, Leila Roshangar, et al.. (2018). Empagliflozin Attenuates Renal and Urinary Markers of Tubular Epithelial Cell Injury in Streptozotocin-induced Diabetic Rats. Indian Journal of Clinical Biochemistry. 35(1). 109–114. 18 indexed citations
12.
Sanajou, Davoud, Amir Ghorbani Haghjo, Hassan Argani, & Somayeh Aslani. (2018). AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions. European Journal of Pharmacology. 833. 158–164. 237 indexed citations
13.
Ahmad, Saeed Nazari Soltan, Nadereh Rashtchizadeh, Hassan Argani, et al.. (2018). Dunnione protects against experimental cisplatin-induced nephrotoxicity by modulating NQO1 and NAD+ levels. Free Radical Research. 52(7). 808–817. 18 indexed citations
14.
Ardalan, Mohammadreza, et al.. (2017). Relationship of Serum Klotho Level With ACE Gene Polymorphism in Stable Kidney Allograft Recipients.. PubMed. 11(2). 151–156. 4 indexed citations
15.
Abbasalizadeh, Shamsi, et al.. (2015). Evaluation of the melatonin and oxidative stress markers level in serum of fertile and infertile women.. SHILAP Revista de lepidopterología. 13(7). 439–44. 12 indexed citations
16.
Haghjo, Amir Ghorbani, et al.. (2014). Correlation of serum osteoprotegerin levels and bone mineral density early after parathyroidectomy in hemodialysis patients. 1 indexed citations
17.
Golzari, Samad EJ, et al.. (2013). Does adenotonsillectomy alter IGF-1 and ghrelin serum levels in children with adenotonsillar hypertrophy and failure to thrive? A prospective study. International Journal of Pediatric Otorhinolaryngology. 77(9). 1541–1544. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026